These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 15991801

  • 1. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI, Atsumi T, Tinahones FJ, Gómez-Zumaquero JM, Amengual O, Khamashta MA, Hughes GR.
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [Abstract] [Full Text] [Related]

  • 4. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 5. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA.
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [Abstract] [Full Text] [Related]

  • 6. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Sep; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 8. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 9. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 10. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
    Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y.
    Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
    [Abstract] [Full Text] [Related]

  • 12. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D, Boutière B, Sanmarco M.
    Ann Biol Clin (Paris); 2000 Jun; 58(5):557-74. PubMed ID: 11022099
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune-mediated atherothrombosis.
    Matsuura E, Lopez LR.
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of antiphospholipid antibodies].
    Atsumi T, Koike T.
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [Abstract] [Full Text] [Related]

  • 16. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
    Barbui T, Finazzi G, Galli M.
    Ann Ital Med Int; 1997 Apr; 12(2):76-83. PubMed ID: 9333316
    [Abstract] [Full Text] [Related]

  • 17. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Apr; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J, Musiał J, Jankowski M, Grzywacz M, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [Abstract] [Full Text] [Related]

  • 19. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
    Becarevic M, Singh S, Majkic-Singh N.
    Clin Lab; 2008 Nov; 54(3-4):97-101. PubMed ID: 18630740
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.